“are there any mods that enforce TOS here?” I
Post# of 157825
(Total Views: 419)
Posted On: 09/15/2021 1:11:54 AM
“are there any mods that enforce TOS here?”
Idk who posted this but yes I’ve been here all day checking in. You can’t have it both ways, as Evil has stated we give leeway within reason. I consider the share price on topic.
Tomorrow is a new day. I’ll leave the post up as I don’t see a major issue with them. Maybe I’ll clean it up a little but nobody has DMd stating they had a major issue with today’s discussion about the share price.
I’m not sure what tomorrow will bring but I’m sure we will have something else to talk about.
If anyone any suggestions/issues pls PM or one of the other mods and we will do our best to resolve any issues.
Idk who posted this but yes I’ve been here all day checking in. You can’t have it both ways, as Evil has stated we give leeway within reason. I consider the share price on topic.
Tomorrow is a new day. I’ll leave the post up as I don’t see a major issue with them. Maybe I’ll clean it up a little but nobody has DMd stating they had a major issue with today’s discussion about the share price.
I’m not sure what tomorrow will bring but I’m sure we will have something else to talk about.
If anyone any suggestions/issues pls PM or one of the other mods and we will do our best to resolve any issues.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36